Riskpilot← Back to searchSign inGet full accessLäkarkonsult Michael Svensson AB
ABActiveOrg 5565222980Porfyrvägen 3General medical practice activities · NACE 8621Est. 19951 employees
Revenue 2025
SEK 726K
-48% vs 2024
EBITDA margin
-58.8%
-346% vs 2024
Equity ratio
97.3%
Financial strength
Net profit 2025
SEK 85K
-95% vs 2024
| Revenue | SEK 726K | -48% |
| EBITDA | SEK -427K | -346% |
| Net profit | SEK 85K | -95% |
| Total assets | SEK 5,2M | -8% |
| Equity | SEK 5,1M | -7% |
| Employees | 1 | — |
Legal name
Läkarkonsult Michael Svensson AB
Org number
5565222980
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 juli 1995
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall verka som leg. läkare med konsultuppdrag, jourarbete, föredrag, utbildnings- och konsultverksamhet inom medicin, arbete såväl i hemmet som på annatsjukhus/vårdcentral samt kapitalförvaltning, dock inte sådan verksamhet som avses i Bankrörelselagen eller lagen om kreditmarknadsbolag och därmed förenlig verksamhet.
Address
Porfyrvägen 3
Phone
+46313380346
Email
michael.svensson@frolundaortopeden.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 375 | 444 | 499 | 1 402 | 726 |
| Staff expenses | — | −940 | −973 | −1 584 | −980 |
| EBITDA | −737 | −654 | −615 | 173 | −427 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −737 | −654 | −615 | 173 | −427 |
| Net financials | 1 206 | 1 123 | 1 201 | 1 523 | 512 |
| Profit before tax | 470 | 469 | 586 | 1 696 | 85 |
| Tax | −0 | — | — | — | — |
| Net profit | 470 | 469 | 586 | 1 696 | 85 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 806 | 4 028 | 4 251 | 5 716 | 5 247 |
| Equity | 3 640 | 3 823 | 4 130 | 5 461 | 5 104 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 166 | 205 | 121 | 255 | 143 |
| Total debt | 166 | 205 | 121 | 255 | 143 |
EBITDA margin
-58.8%
This company
15.8%
Market median
-472% vs market
20212025
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20212025
Return on equity
1.7%
This company
18.4%
Market median
-91% vs market
20212025
Net profit margin
11.8%
This company
8.1%
Market median
+46% vs market
20212025
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LÅ Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkarkonsult Michael Svensson AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Åke Ahlert | Audit | 0 companies |
| Alexander William Hendelberg | Deputy Board Member | 0 companies |
| Jan Michael Hendelberg | Board of Directors | 0 companies |